Scott Becker

Their main weight loss drug is Letgovi, but they're basically seeing themselves splash their forecast and sales and profit forecast for that.

It's another example that when you're going after stuff and you've got this great excess profits, that other parties are going to come after you and try and eat into that as well.

They're seeing a lot of that.

They're aggressively cutting their profits.

forecast, the stock is down more than 50% over the past year as they faced increased competition from others like hims and hers, Eli Lilly and others.

This is Scott Becker with the Becker Business Podcast and the Becker Private Equity Podcast.

Today's discussion is five stocks.

taking it on the chin.

So we're watching several different stocks that are really having a struggling day today.

And we'll talk through just a few of those just really quick and give you the quick highlights, the quick sense of what's going on.

First, we've got Novo Nordisk, which we'll talk about in a separate podcast, down more than 20% as more and more competition comes to the GLP market and they cut their guidance for the year.

Second, UnitedHealthcare down again, another more than 5% today.

They're down 46% year-to-date.

Things are getting tougher and tougher in the world of UnitedHealthcare.

UnitedHealthcare, of course, is the fourth or fifth largest company in the United States by revenues, so we're watching that.

Third, Spotify, the podcast firm, down about 11% today, and more and more challenges in their business.

Fourth, UPS down again about 10% today.

We're huge fans of UPS.

We use it almost daily.

They've got a great UPS right near us here where we live.